Article
Author(s):
Newark, NJ-Topical beta-blockers are much safer than physicians believe them to be, according to New Jersey glaucoma specialist Paul Lama, MD.
Bausch + Lomb voluntarily recalls select enVista IOLs
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Electroretinography reveals limited duration of dexamethasone implant efficacy in DME
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Beyond mentoring: The power of sponsorship and advocacy in ophthalmology
Nanoscope Therapeutics publishes clinical data on vision restoration in retinitis pigmentosa